Funding, News and Announcements

This competitive grant program is part of Pfizer's ongoing commitment to translate scientific discoveries into innovative medicines for patients with cardiovascular disease. The NASH ASPIRE program will evaluate submitted research proposals that cover areas in basic, clinical, and translational sciences. Innovative, feasible, rigorous research proposals with the potential of high impact in advancing the learning about NASH will be prioritized. 

Individual projects requesting up to USD $140,000 will be considered. The estimated total available budget related to this RFP is USD $420,000 

Full details are available here.

Internal Deadline: December 21, 2023 at 4:30pm. Contact email is ird@dal.ca.

Funder Deadline: January 4, 2024. Contact email is jessica.romano@pfizer.com.